UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.253

Sortiert nach

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States

Journal of the American College of Cardiology, 2020-09, Vol.76 (13), p.1521-1531

2020

Volltextzugriff (PDF)

Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors

Journal of the American College of Cardiology, 2016-03, Vol.67 (8), p.921-931

2016

Volltextzugriff (PDF)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Cardiovascular diabetology, 2021-07, Vol.20 (1), p.137-137, Article 137

2021

Volltextzugriff (PDF)

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

Circulation (New York, N.Y.), 2014-01, Vol.129 (2), p.211-223

2014

Volltextzugriff (PDF)

Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: Nordic Bifurcation Study 5-Year Follow-Up Results

Journal of the American College of Cardiology, 2013-07, Vol.62 (1), p.30-34

2013

Volltextzugriff (PDF)

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

The New England journal of medicine, 2015-03, Vol.372 (13), p.1204-1212

2015

Volltextzugriff (PDF)

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

The Lancet (British edition), 2012-04, Vol.379 (9824), p.1393-1402

2012

Volltextzugriff (PDF)

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease

The New England journal of medicine, 2015-03, Vol.372 (13), p.1213-1222

2015

Volltextzugriff (PDF)

Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers

JACC. Cardiovascular interventions, 2016-06, Vol.9 (11), p.1115-1123

2016

Volltextzugriff (PDF)

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

Circulation (New York, N.Y.), 2012-01, Vol.125 (3), p.505-513

2012

Volltextzugriff (PDF)

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials

Circulation (New York, N.Y.), 2012-06, Vol.125 (23), p.2873-2891

2012

Volltextzugriff (PDF)

One-Year Outcome of Small-Vessel Disease Treated with Sirolimus-Eluting Stents: A Subgroup Analysis of the e-SELECT Registry

Journal of interventional cardiology, 2013-04, Vol.26 (2), p.163-172

2013

Volltextzugriff (PDF)

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries

Diabetes care, 2004-07, Vol.27 (7), p.1840-1841

2004

Volltextzugriff (PDF)

Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography

Heart (British Cardiac Society), 2014-01, Vol.100 (2), p.153-159

2014

Volltextzugriff (PDF)

Diabetes and restenosis

Cardiovascular diabetology, 2022-02, Vol.21 (1), p.23-14, Article 23

2022

Volltextzugriff (PDF)

Stent thrombosis in randomized clinical trials of drug-eluting stents

The New England journal of medicine, 2007-03, Vol.356 (10), p.1020-1029

2007

Volltextzugriff (PDF)

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents

The New England journal of medicine, 2007-03, Vol.356 (10), p.1030-1039

2007

Volltextzugriff (PDF)

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial

Circulation (New York, N.Y.), 2016-01, Vol.133 (2), p.131-138

2016

Volltextzugriff (PDF)

Restenosis after PCI. Part 1: pathophysiology and risk factors

Nature reviews cardiology, 2012-01, Vol.9 (1), p.53

2012

Volltextzugriff (PDF)

Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

Canadian journal of cardiology, 2020-10, Vol.36 (10), p.1624-1632

2020

Volltextzugriff (PDF)

Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry

JACC. Cardiovascular interventions, 2011-08, Vol.4 (8), p.844-850

2011

Volltextzugriff (PDF)

Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2021-08, Vol.17 (5), p.e380

2021

Volltextzugriff (PDF)

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

JAMA : the journal of the American Medical Association, 2008-04, Vol.299 (16), p.1903

2008

Volltextzugriff (PDF)

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

Cardiovascular diabetology, 2019-01, Vol.18 (1), p.11-11, Article 11

2019

Volltextzugriff (PDF)

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2020-04, Vol.15 (17), p.1527

2020

Volltextzugriff (PDF)

1 – 25 von 1.253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.176)
Mit Volltextzugriff
(1.081)

Publikationsform

Artikel
(1.253)

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.245)
Science & Technology
(1.055)
Life Sciences & Biomedicine
(1.048)
Male
(983)
Female
(970)
Cardiovascular System & Cardiology
(895)
Cardiac & Cardiovascular Systems
(861)
Middle Aged
(845)
Coronary Restenosis - Epidemiology
(843)
Aged
(763)
Stents
(607)
Treatment Outcome
(590)
Follow-Up Studies
(539)
Coronary Angiography
(498)
Biological And Medical Sciences
(455)
Medical Sciences
(454)
Risk Factors
(431)
Incidence
(392)
Restenosis
(363)
Cardiology. Vascular System
(333)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States

Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: Nordic Bifurcation Study 5-Year Follow-Up Results

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease

Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials

One-Year Outcome of Small-Vessel Disease Treated with Sirolimus-Eluting Stents: A Subgroup Analysis of the e-SELECT Registry

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries

Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography

Diabetes and restenosis

Stent thrombosis in randomized clinical trials of drug-eluting stents

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial

Restenosis after PCI. Part 1: pathophysiology and risk factors

Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry

Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Suchergebnisse filtern